Taro Fujimori is a CMC Team Leader and Director at Ultragenyx Gene Therapy. Taro has a PhD in Biophysics (Brandeis), an MBA (Columbia University), and a BA in Biophysics (UPenn). Taro has worked in pharmaceutical research, development, and operations bringing novel therapeutics to clinical trials and market. |